About: http://data.cimple.eu/news-article/d91551cf2a01ab3f7279cdba07faeb982387554bcc6fd3ddc9aa3a91

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/d91551cf2a01ab3f7279cdba07faeb982387554bcc6fd3ddc9aa3a91 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	A Cuban-developed coronavirus candidate vaccine entered into Phase III trials Thursday, the first shot developed by a Latin American country to get this far, the government said. The recruitment of 44,000 volunteers aged 19 to 80 to test the drug named Soberana 2 has already begun, said Cuba's Finlay vaccine institute. The first trial shots should start being administered in Havana next week. The trial volunteers will be divided into three groups: some will receive two doses of the vaccine 28 days apart, another group will get two doses plus a third immune booster, and the third a placebo. This third phase of the trial will officially end three months after the last dose is injected, the institute's Yury Valdes told reporters. But if the results are promising, authorization for emergency use could be sought before then. The communist state, which has stated it wants to vaccinate all inhabitants this year, has been relatively unscathed by the Covid-19 pandemic, with just over 53,300 recorded cases and 336 deaths in a population of 11.2 million. Under American sanctions, the island nation began developing its own vaccines in the 1980s, discovering the first immunization against the meningitis-causing Meningococcal B bacteria. Nearly 80 percent of its vaccines are produced locally, and Cuba is working on four coronavirus candidate vaccines. Soberana 2, like Novavax developed in America, is a recombinant protein vaccine. They work by recreating the "spikes" on the surface of the coronavirus and introducing it to the body, training the immune system to recognize such intruders and fight back in case of a real infection. Recombinant vaccines, unlike some coronavirus shots already in use, do not need extreme refrigeration. ka/fjb/mlr/sst
schema:headline	Cuban-developed vaccine enters Phase III trial
schema:mentions	Novavax Pathogenic bacteria Immunization Havana Placebo Immune system Cuba Pandemic Vaccine United States Coronavirus Coronavirus disease 2019 Dave Finlay Recombinant DNA Refrigeration Latin music Singapore Standard Time
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	80 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software